News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Resistance news

Show

From To
Resistance
Boosted PIs superior to no PIs as salvage therapy in highly PI-experienced

A small Italian study comparing boosted protease inhibitor (PI) and PI-sparing salvage regimens in the highly PI-experienced has found the former superior in preserving CD4

Published
24 April 2004
By
Edwin J. Bernard
Resistance
2NN study full results: nevirapine inferior to efavirenz?

Final results of a major international comparative study of nevirapine or efavirenz-based triple antiretroviral therapy suggest that nevirapine-based HAART may have proved inferior to efavirenz-based

Published
16 April 2004
By
Keith Alcorn
Resistance
Four year follow-up shows Kaletra to be safe, effective, durable

Lopinavir/ritonavir (KaletraTM) has a potent and durable anti-HIV effect when used in combination with d4T and 3TC, and a good side-effect profile, according to a

Published
05 April 2004
By
Michael Carter
Resistance
Resistant HIV strains persist after at least five years on suppressive HAART

Drug-resistant strains of HIV can remain archived in the reservoir of latently infected cells for five years or more after a successfully suppressive HAART regime,

Published
26 March 2004
By
Edwin J. Bernard
Testing and health monitoring
HIV envelope may hold clues to likely treatment response

Researchers at the British Columbia Centre for Excellence in HIV/AIDS may have discovered a cheap way of identifying those at higher risk of treatment failure

Published
12 March 2004
By
Keith Alcorn
Resistance
Variations in the P-gp gene do not affect disease progression rates

Pharmacogenomics, the study of genetic predisposition to medicines, is an emerging area of medical research. Its application in HIV medicine is still in its infancy.

Published
23 February 2004
By
Bob Huff - Editor, GMHC Treatment Issues, New York
Resistance
Transmission of drug-resistant HIV: what are the implications for treatment?

Although drug resistance may linger for months or even years when individuals become infected with a drug resistant virus, evidence from a large European study

Published
12 February 2004
By
Keith Alcorn
Resistance
Different resistance patterns seen with subtype C HIV in Brazil

Treatment of people infected with HIV B and non-B subtypes in southern Brazil has shown that viral subtype influences likely resistance mutations, according to a

Published
11 December 2003
By
Megan Nicholson
Resistance
Minority can have CD4 rises and no illness for more than 3 years after treatment failure

People with a stable low detectable viral load who continue with existing treatment continue to have rising CD4 cell counts and no clinical progression for

Published
11 December 2003
By
Edwin J. Bernard
Clinical trials
Triple PI salvage therapy

Salvage therapy with three protease inhibitors alongside nucleoside analogues or the NNRTI efavirenz is being explored by clinicians at the Royal Free Hospital in London. They

Published
05 March 2001
By
Keith Alcorn
← Prev1...3536373839Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.